CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AB6. A total of 28 filers reported holding CLOVIS ONCOLOGY INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $1,596,000 | +5.8% | 1,629,000 | +2.3% | 0.04% | +2.9% |
Q1 2021 | $1,509,000 | +11.4% | 1,592,000 | +8.2% | 0.04% | 0.0% |
Q4 2020 | $1,354,000 | -1.0% | 1,472,000 | 0.0% | 0.04% | -14.6% |
Q3 2020 | $1,368,000 | -43.0% | 1,472,000 | -44.7% | 0.04% | -46.1% |
Q2 2020 | $2,398,000 | -27.5% | 2,664,000 | -26.7% | 0.08% | -35.0% |
Q1 2020 | $3,309,000 | +2.3% | 3,636,000 | 0.0% | 0.12% | +27.2% |
Q4 2019 | $3,236,000 | +2.2% | 3,636,000 | 0.0% | 0.09% | -5.2% |
Q3 2019 | $3,165,000 | -2.1% | 3,636,000 | 0.0% | 0.10% | -3.0% |
Q2 2019 | $3,234,000 | -4.1% | 3,636,000 | -0.1% | 0.10% | -7.4% |
Q1 2019 | $3,374,000 | +9.5% | 3,641,000 | +0.1% | 0.11% | -4.4% |
Q4 2018 | $3,080,000 | +163.2% | 3,639,000 | +191.1% | 0.11% | +253.1% |
Q3 2018 | $1,170,000 | -13.3% | 1,250,000 | 0.0% | 0.03% | -17.9% |
Q2 2018 | $1,349,000 | +131.0% | 1,250,000 | +150.0% | 0.04% | +95.0% |
Q1 2018 | $584,000 | -14.0% | 500,000 | 0.0% | 0.02% | -13.0% |
Q4 2017 | $679,000 | -12.7% | 500,000 | 0.0% | 0.02% | -17.9% |
Q3 2017 | $778,000 | -8.1% | 500,000 | 0.0% | 0.03% | -12.5% |
Q2 2017 | $847,000 | +31.3% | 500,000 | 0.0% | 0.03% | +28.0% |
Q1 2017 | $645,000 | +25.0% | 500,000 | 0.0% | 0.02% | +31.6% |
Q4 2016 | $516,000 | +7.3% | 500,000 | -0.4% | 0.02% | +11.8% |
Q3 2016 | $481,000 | +14.5% | 502,000 | -14.3% | 0.02% | +13.3% |
Q2 2016 | $420,000 | +4.7% | 586,000 | 0.0% | 0.02% | +15.4% |
Q1 2016 | $401,000 | -7.6% | 586,000 | +16.3% | 0.01% | -7.1% |
Q4 2015 | $434,000 | -55.3% | 504,000 | -13.6% | 0.01% | -51.7% |
Q3 2015 | $971,000 | – | 583,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
QVT Financial LP | 43,295,000 | $29,665,000 | 1.82% |
Telemetry Investments, L.L.C. | 7,000,000 | $4,747,000 | 1.38% |
Baker Brothers Advisors | 129,300,000 | $87,801,000 | 0.93% |
Castle Creek Arbitrage, LLC | 5,500,000 | $3,755,000 | 0.30% |
WOLVERINE ASSET MANAGEMENT LLC | 14,300,000 | $9,730,000 | 0.28% |
Verition Fund Management LLC | 1,966,000 | $1,343,000 | 0.22% |
UBS OCONNOR LLC | 11,625,000 | $7,960,000,000 | 0.15% |
CAPSTONE INVESTMENT ADVISORS, LLC | 6,000,000 | $4,106,000 | 0.12% |
PFM Health Sciences, LP | 4,747,000 | $3,243,000 | 0.10% |
ARROWGRASS CAPITAL PARTNERS (US) LP | 11,500 | $3,568,000 | 0.04% |